“Hepatocellular carcinoma (HCC) is the leading cause of cancer-associated mortality worldwide; however, only limited therapeutic treatments are currently available.

The present study aimed to investigate the effects of cannabinoids as novel therapeutic targets in HCC…

These results suggested that cannabinoid receptor agonists, including WIN, may be considered as novel therapeutics for the treatment of HCC.”

http://www.ncbi.nlm.nih.gov/pubmed/26500101

http://www.thctotalhealthcare.com/category/hepatocellular-carcinoma-hcc/